Kalshi, a prediction market platform, has teamed up with AppliedXL, a public intelligence company, to introduce a new pilot program. This initiative allows participants to trade on the outcomes of clinical trials and decisions made by the Food and Drug Administration (FDA).
The launch of this program marks a significant step in utilizing prediction markets to gauge public sentiment and expectations regarding medical advancements and regulatory approvals.
By enabling trading on these critical outcomes, Kalshi and AppliedXL aim to provide valuable insights into the healthcare sector, potentially influencing investment and research decisions.